ABVX
Abivax · USD
Deep AI analysis (big model)
No deep analysis yet. Portfolio holdings are analysed automatically; for any other stock, click “Request deep AI analysis” above.
About Abivax
Abivax (ABVX) is a biopharmaceutical company focused on developing immunotherapies for infectious diseases, though I don't have specific information about its core products or services beyond this general focus.
| Ticker | ABVX |
| Name | Abivax |
| Currency | USD |
Reputation
Reputation builds as news about this company is analysed.
Price history & forecast
30-day forecast — Linear regression, Holt's exponential smoothing, and drift, plus a news-adjusted consensus (sentiment tilt +0.00). Estimates only, not advice.
Candlestick, volume & news sentiment
Daily open/high/low/close candles with volume bars beneath; hover a candle for its OHLC, change and volume. Dots mark analysed news coloured by sentiment. Pick a range, or click-and-drag across the chart to zoom in.
Forecast accuracy (backtested)
No scored forecasts yet. Every visit records the day's forecast; once those predicted dates pass, this table fills in with how each method actually did (1 snapshot(s) recorded so far, none matured yet).
Technical analysis
BEARISHComputed from 252 locally-stored price bars.
AI signals
-
HOLD 70% · long_term 2026-06-07 23:28
The stock has been in a downtrend with significant losses over the past week, dropping from its recent high of 129.69 to the current level at 101.53. The lack of positive news or analyst reports further supports this bearish view. While there is no immediate catalyst for an upward move, the stock's price action suggests caution and a potential long-term sell-off scenario.
qwen2.5:3b
Related news
- No matched headlines yet.